Loading ...

hybrid erlotinib hydrochloride/HPMCP HP55 nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

hydroxypropyl methylcellulose phthalate

HPMCP HP55
Type Biomolecule
Formula
Role binder
2

erlotinib hydrochloride

Type Single Compound
Formula C22H24ClN3O4
Role fillers

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
dissolution kinetics in FaSSIF

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • hydroxypropyl methylcellulose phthalate
  • erlotinib hydrochloride
  1. lH1lbOS4JeTP2
  2. KObZv8MSipIdEanc6Ok1q89OQ2AERFWtyQsjezWdVrfR
  3. D4YNcxa
  4. jbruW
Product

hybrid erlotinib hydrochloride/HPMCP HP55 nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:


Sign up for a free trial